Surgical factors influence bladder cancer outcomes: A cooperative group report

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2781-2789

  Herr, Harry W ^a   Faulkner, James R ^a   Grossman, H Barton ^a   Natale, Ronald B ^a   deVere White, Ralph ^a   Sarosdy, Michael F ^a   Crawford, E David ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADJUVANT THERAPY; AGED; BLADDER TUMOR; CANCER STAGING; FEMALE; HOSPITAL; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGY; STATISTICS; SURVIVAL; TUMOR RECURRENCE; UNITED STATES; URINARY DIVERSION; UROLOGY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYSTECTOMY; FEMALE; HOSPITALS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; URINARY BLADDER NEOPLASMS; URINARY DIVERSION; UROLOGY;

EID: 4344652971     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.11.024     Document Type: Article

References (9)

1. Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19:666-675, 2001
2. Madersbacher S, Hochreiter W, Burkhard F, et al: Radical cystectomy for bladder cancer: A homogeneous series with neoadjuvant therapy. J Clin Oncol 21:690-696, 2003
3. Grossman HB, Natale RB, Tangen CM, et al: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866, 2003
4. Leissner J, Hohenfellner R, Thuroff JW, et al: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: Significance for staging and prognosis. BMJ Int 85:817-821, 2000
5. Herr HW, Bochner BH, Dalbagni G, et al: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295-1298, 2002
6. Konety BR, Joslyn SA, O'Donnell MA: Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the Surveillance, Epidemiology and End Results program data base. J Urol 169:946-950, 2003
7. Murphy WM, Crissman JD, Johansson SL, et al: Recommendations for the reporting of urinary bladder specimens containing bladder neoplasms. Am J Clin Pathol 106:568-570, 1996
8. Hammond EH, Henson DE, for members of College of American Pathologists: Practice protocol for the examination of specimens removed from patients with carcinoma of the urinary bladder. Arch Pathol Lab Med 120:1103-1110, 1996
9. Herr HW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 61:105-108, 2003